Bristol-Myers warns I-O blockbuster Opdivo will be 'under pressure' in 2020

31st October 2019 Uncategorised 0

Bristol-Myers Squibb’s Eliquis has looked like a world-beater as it continues to rake in market share and keep a stranglehold on its anticoagulant rivals. But another Bristol blockbuster—I-O med Opdivo—hit something of a wall in the third quarter, and execs are warning that it’ll face a tough 2020.

More: Bristol-Myers warns I-O blockbuster Opdivo will be 'under pressure' in 2020
Source: fierce